focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksClontarf Regulatory News (CLON)

Share Price Information for Clontarf (CLON)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0425
Bid: 0.04
Ask: 0.045
Change: 0.00 (0.00%)
Spread: 0.005 (12.50%)
Open: 0.0425
High: 0.0425
Low: 0.04
Prev. Close: 0.0425
CLON Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

JV HoA on Direct Lithium Ion Extraction in Bolivia

15 Feb 2023 07:00

RNS Number : 9364P
Clontarf Energy PLC
15 February 2023

15th February 2023


Clontarf Energy plc

("Clontarf" or "the Company")


JV HoA on Direct Lithium Ion Extraction Technology in Bolivia.



Clontarf Energy plc (AIM: CLON) is pleased to announce a heads of agreement around the potential formation of a 50:50 Joint Venture with US based, OTC Markets traded, technology company, NEXT-ChemX Corporation ("NCX") covering testing, marketing, and deploying of NCX's proprietary (patent pending) direct lithium ion extraction ("DLE") technology in Bolivia. Formation of the JV is subject to final due diligence and the parties entering into formal documentation, which is intended to occur within the next 30 days.


NCX's ion extraction technology uses the surface area of hollow fibre membranes to extract lithium ions from brines. The technology is a continuous process, and does not require high pressure, temperature or electrolysis. It does not rely on osmotic processes, or costly filtration techniques electrolysis, but instead mimics biophysical processes of natural principals to induce ions in solution to cross the membrane barrier. This mimics how mammal organisms remove wastes from a donor liquid without physically mixing with an acceptor liquid. 


The technology has been proven to be effective and efficient during laboratory testing, and in the Board's view, NCX's technology is an innovative approach to direct lithium extraction.


Environmental attractions include limited energy and water consumption, extracting the targeted ions and generating minimal waste. It is suited for lithium extraction from Bolivian brines, where evaporative ponds are not optimal due to rainfall conditions, altitude and magnesium content. 


Laboratory / bench test analyses extracted ions from solutions at ambient temperatures and pressures - even in very low concentrations.


The next step is to test selected brines from potential sources. NCX is assembling, subject to funding being delivered from Clontarf (per the below), a pilot plant in Texas to test large volumes of brines, moving towards feasibility and commercialisation. The plant will test circa 1,000 litres of each specific brine, with an overall 20,000 litre trial run size, allowing a customised NCX DLE commercial system to be assembled (in modular form) and placed on site for field testing.



The NCX DLE Technology is patent pending, with intellectual property protection managed by Patent Attorneys specialised in chemical processing and materials science.


Clontarf is in discussions with Bolivia's state owned lithium company ("YLB") to test NCX's proprietary DLE membrane technology on priority brines, which may include identified salares on which preliminary samples have been taken.


Negotiations with the proper authorities covering the source and volumes of brines to be processed, and on which commercial terms, are expected to follow successful pilot plant operation - subject to applicable laws.

The pilot plant testing and extraction will begin during March 2023, including both preliminary testing, as well as pilot plant operations, with results expected by May 2023.



Heads of Agreement Terms:


A 50:50 joint venture company to be formed on completion of due diligence covering the exclusive rights to the marketing, testing and deployment of the NCX DLE technology in Bolivia.


Clontarf Energy plc to contribute $500,000 towards the pilot plant construction and testing as an exclusivity fee for the use of the NCX technology.


NCX will then issue shares equal to $500,000 at its next financing (CHMX:OTC) to Clontarf Energy plc


Clontarf Energy plc will issue shares as follows to NCX:

i. 385 million new Ordinary Shares on proceeding with the Pilot Plant $500,000 contribution from Clontarf;


ii. 250 million new Ordinary Shares after successful pilot processing of Bolivian brines through the NCX pilot plant; and


iii. 250 million new Ordinary Shares after entry into a construction and processing contract between the JV and the Bolivian authorities on processing of Bolivian brines utilising NCX processing technology.



NCX, or its nominee, will have the right, but not the obligation, to invest £250,000 into the Company at a price of £0.00065, for 30 days from the signature of this HoA.


As noted above, formation of the JV is subject to final due diligence and the parties entering into formal documentation (based on the terms of the Heads of Agreement), which is intended to occur within the next 30 days.


Chairman, David Horgan, commented:


"The world needs a dramatic increase in battery grade lithium salts output. Projected global demand cannot be delivered without major Bolivian output. The delay has been the shortcomings of evaporative ponds at high altitude, some rainfall and impurity levels.


"We believe that these constraints may be bypassed through innovative technology.


"In minimising environmental impact, we have worked to reduce water use by 95%, and minimise the footprint of on-site operations.


"Any Bolivian operations will conform with applicable laws, in partnership with the State Lithium Company, and respect high international operating standards."





This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR").





For further information please visit or contact:


Clontarf Energy

David Horgan, Chairman

Jim Finn, Director

+353 (0) 1 833 2833

Nominated & Financial Adviser

Strand Hanson Limited

Rory Murphy

Ritchie Balmer

+44 (0) 20 7409 3494


Novum Securities Limited

Colin Rowbury

+44 (0) 207 399 9400

Public Relations


Megan Ray

+44 (0) 207 138 3206



Luke Hogg

Alan Tyrrell


+353 (0) 1 661 4055







This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Date   Source Headline
15th May 202411:23 amRNSBolivia Lithium Update
10th Apr 20241:35 pmRNSGrant of Share Options
18th Mar 20247:00 amRNSBolivia Update, Fundraising and TVR
6th Mar 202410:33 amRNSEncouraging Bolivian Brines Progress
5th Feb 20247:00 amRNSSouth American Brines Progress
25th Sep 20237:00 amRNSInterim Results for the period ended 30 June 2023
1st Aug 202310:38 amRNSGrant of Share Options
13th Jul 202312:35 pmRNSResult of AGM and Corporate Update
22nd Jun 202312:32 pmRNSPosting of Annual Report and Notice of AGM
8th Jun 20237:00 amRNSPreliminary Results
1st Jun 20237:00 amRNS£350,000 Fundraising and Corporate Update
5th May 20237:00 amRNSUpdate on Joint Venture Agreement and TVR
28th Mar 202310:24 amRNSJV Agreement on Direct Lithium Extraction Bolivia
17th Feb 202311:05 amRNSSecond Price Monitoring Extn
17th Feb 202311:00 amRNSPrice Monitoring Extension
15th Feb 20237:00 amRNSJV HoA on Direct Lithium Ion Extraction in Bolivia
17th Jan 202310:34 amRNSGrant of Share Options
16th Jan 20237:00 amRNS£1.3 million Fundraising and Corporate Update
8th Nov 20224:40 pmRNSSecond Price Monitoring Extn
8th Nov 20224:35 pmRNSPrice Monitoring Extension
22nd Sep 20227:00 amRNSInterim Results for the period ended 30 June 2022
5th Sep 20227:02 amRNSShare Price Movement and Shareholder Update
4th Aug 20221:00 pmRNSResult of AGM and Capital Reorganisation
1st Jul 202211:04 amRNSDirector Change
29th Jun 202210:30 amRNSPosting of Annual Report
22nd Jun 20227:00 amRNSPreliminary Results for the Year Ended 31 Dec 2021
14th Jun 20227:00 amRNSSasanof-1 well completion
6th Jun 20227:00 amRNSSasanof-1 well final result
6th Jun 20227:00 amRNSResult of General Meeting
30th May 20228:00 amRNSSasanof-1 well drilling update
27th May 20227:00 amRNSSasanof-1 well spudding
23rd May 20227:00 amRNSSasanof-1 well mobilisation update
20th May 20224:41 pmRNSSecond Price Monitoring Extn
20th May 20224:36 pmRNSPrice Monitoring Extension
18th May 20222:06 pmRNSSecond Price Monitoring Extn
18th May 20222:00 pmRNSPrice Monitoring Extension
18th May 20227:00 amRNSSasanof-1 well mobilisation update
17th May 202211:00 amRNSPrice Monitoring Extension
12th May 202211:53 amRNSUpdate on Sasanof-1 well
11th May 20223:58 pmRNSNotice of General Meeting
10th May 20227:00 amRNSConsideration Shares to be Admitted to Trading
9th May 20227:00 amRNSAcquisition of 10% of Sasanof Prospect
27th Apr 20221:02 pmRNSPlacing to raise £3,500,000
12th Jan 20224:40 pmRNSIssue of Warrants and RPT
20th Sep 20214:41 pmRNSSecond Price Monitoring Extn
20th Sep 20214:36 pmRNSPrice Monitoring Extension
15th Sep 20217:00 amRNSInterim Statement
23rd Jun 202111:35 amRNSResult of Annual General Meeting and Board Changes
7th Jun 202110:50 amRNSPosting of Annual Report and Notice of AGM
24th May 20214:11 pmRNSTR-1: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.